328 related articles for article (PubMed ID: 19224889)
41. Evaluation of a patient with hyper-IgM syndrome.
Uygungil B; Bonilla F; Lederman H
J Allergy Clin Immunol; 2012 Jun; 129(6):1692-3.e4. PubMed ID: 22657410
[No Abstract] [Full Text] [Related]
42. IgG2 deficiency in ataxia-telangiectasia.
Oxelius VA; Berkel AI; Hanson LA
N Engl J Med; 1982 Mar; 306(9):515-7. PubMed ID: 7057859
[No Abstract] [Full Text] [Related]
43. [Clinical and immunological profile of 15 Moroccan patients with Hyper IgM syndrome].
Ouair H; Benhsaien I; Jeddane L; El Bakkouri J; Elhafidi N; Rada N; Najib J; Ailal F; Alj HS; Bousfiha AA
Pan Afr Med J; 2017; 26():212. PubMed ID: 28690727
[TBL] [Abstract][Full Text] [Related]
44. IgG2 deficiency and ataxia-telangiectasia.
Yount WJ
N Engl J Med; 1982 Mar; 306(9):541-3. PubMed ID: 7057862
[No Abstract] [Full Text] [Related]
45. The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management.
Yazdani R; Fekrvand S; Shahkarami S; Azizi G; Moazzami B; Abolhassani H; Aghamohammadi A
Clin Immunol; 2019 Jan; 198():19-30. PubMed ID: 30439505
[TBL] [Abstract][Full Text] [Related]
46. Primary and secondary abnormalities of T cell subpopulations.
Trompeter RS; Layward L; Hayward AR
Clin Exp Immunol; 1978 Dec; 34(3):388-92. PubMed ID: 311259
[TBL] [Abstract][Full Text] [Related]
47. Hyper-immunoglobulin M syndrome type 3 with normal CD40 cell surface expression.
Karaca NE; Forveille M; Aksu G; Durandy A; Kutukculer N
Scand J Immunol; 2012 Jul; 76(1):21-5. PubMed ID: 22443339
[TBL] [Abstract][Full Text] [Related]
48. Ataxia-telangiectasia. X,14 translocation, progressive deterioration of lymphocyte numbers and function, and abnormal in vitro immunoglobulin production.
Beatty DW; Arens LJ; Nelson MM
S Afr Med J; 1986 Jan; 69(2):115-8. PubMed ID: 2417340
[TBL] [Abstract][Full Text] [Related]
49. Alpha fetoprotein is increasing with age in ataxia-telangiectasia.
Stray-Pedersen A; Borresen-Dale AL; Paus E; Lindman CR; Burgers T; Abrahamsen TG
Eur J Paediatr Neurol; 2007 Nov; 11(6):375-80. PubMed ID: 17540590
[TBL] [Abstract][Full Text] [Related]
50. Hyper IgM syndrome presenting as chronic suppurative lung disease.
Montella S; Maglione M; Giardino G; Di Giorgio A; Palamaro L; Mirra V; Ursini MV; Salerno M; Pignata C; Caffarelli C; Santamaria F
Ital J Pediatr; 2012 Sep; 38():45. PubMed ID: 22992442
[TBL] [Abstract][Full Text] [Related]
51. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
52. [Ataxia telangiectasia: review of 13 new cases].
Valbuena O; Póo P; Campistol J; Vernet A; Fernández-Alvarez E; Sierra I; Gean E
Rev Neurol; 1996 Jan; 24(125):77-80. PubMed ID: 8852005
[TBL] [Abstract][Full Text] [Related]
53. Ataxia-telangiectasia in brother and sister.
Penchaszadeh VB
Birth Defects Orig Artic Ser; 1971 Jun; 7(8):324-5. PubMed ID: 5173302
[No Abstract] [Full Text] [Related]
54. Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia.
Kitchen BJ; Boxer LA
Pediatr Blood Cancer; 2008 Jan; 50(1):142-5. PubMed ID: 16767728
[TBL] [Abstract][Full Text] [Related]
55. Autosomal recessive hyper IgM syndrome associated with activation-induced cytidine deaminase gene in three Turkish siblings presented with tuberculosis lymphadenitis - Case report.
Patiroglu T; Akar HH; van der Burg M; Unal E
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):267-74. PubMed ID: 26551569
[TBL] [Abstract][Full Text] [Related]
56. Causative mechanisms and clinical impact of immunoglobulin deficiencies in ataxia telangiectasia.
Takada S; Weitering TJ; van Os NJH; Du L; Pico-Knijnenburg I; Kuipers TB; Mei H; Salzer E; Willemsen MAAP; Weemaes CMR; Pan-Hammarstrom Q; van der Burg M
J Allergy Clin Immunol; 2024 May; 153(5):1392-1405. PubMed ID: 38280573
[TBL] [Abstract][Full Text] [Related]
57. Unusual clinical manifestations and predominant stopgain ATM gene variants in a single centre cohort of ataxia telangiectasia from North India.
Rawat A; Tyagi R; Chaudhary H; Pandiarajan V; Jindal AK; Suri D; Gupta A; Sharma M; Arora K; Bal A; Madaan P; Saini L; Sahu JK; Ogura Y; Kato T; Imai K; Nonoyama S; Singh S
Sci Rep; 2022 Mar; 12(1):4036. PubMed ID: 35260754
[TBL] [Abstract][Full Text] [Related]
58. Twenty-year follow-up of 160 patients with ataxia-telangiectasia.
Ersoy F; Berkel AI; Sanal O; Oktay H
Turk J Pediatr; 1991; 33(4):205-15. PubMed ID: 1814037
[TBL] [Abstract][Full Text] [Related]
59. Studies on lymphocyte cell surface in ataxia-telangiectasia.
Ozer NK; Ciliv G; Berkel AI; Sanal O; Yeğin O; Ersoy F
Clin Exp Immunol; 1985 Jul; 61(1):118-24. PubMed ID: 2994921
[TBL] [Abstract][Full Text] [Related]
60. [Ataxia telangiectasia and characterization of its immunological disorders].
Matsumoto S; Sakiyama Y; Kajii N; Okano M; Ishizaka A; Ariga T
No To Hattatsu; 1990 Mar; 22(2):103-11. PubMed ID: 2158803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]